GeneDx Reports Second Quarter 2026 Financial Results
Go back to GeneDx Reports Second Quarter 2026 Financial Results| (NASDAQ: WGS) | Delayed: 73.09 +2.13 (3.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.96 | 52 Week High | $ | |||
| Open | $71.13 | 52 Week Low | $ | |||
| Day High | $74.86 | P/E | N/A | |||
| Day Low | $70.48 | EPS | $ | |||
| Volume | 606,695 | |||||

